Living with a pulmonary arterial hypertension (PAH) diagnosis can be challenging, but there are treatment options available to help manage this condition. One such option is Flolan, a medication that works by dilating blood vessels in the lungs and improving blood flow. In this blog post, we'll explore the benefits of Flolan for patients and caregivers alike. From its mechanism of action to potential side effects, we've got you covered on everything you need to know about Flolan. So let's dive in!
Flolan, also known as epoprostenol sodium, is a medication that helps treat pulmonary arterial hypertension (PAH). This condition causes high blood pressure in the arteries of your lungs and can make it difficult for your heart to pump blood. Flolan works by dilating these constricted arteries, allowing for better blood flow.
The drug is administered through an IV directly into the bloodstream. Patients who use Flolan typically require continuous infusion therapy due to its short half-life. While this may seem daunting, many patients find that the benefits of Flolan outweigh any inconvenience its administration may cause.
Flolan, also known as epoprostenol sodium, is a medication that helps to dilate blood vessels in the lungs. This allows for improved blood flow and oxygenation in patients with pulmonary arterial hypertension (PAH) or related conditions.
One of the key benefits of Flolan is its ability to improve exercise tolerance and reduce symptoms such as shortness of breath and fatigue. Patients may be able to engage in physical activity more easily, improving their quality of life.
Another important benefit is Flolan's ability to prolong survival and improve hemodynamics (blood flow) in PAH patients. Studies have shown that treatment with Flolan can significantly increase 1-year survival rates compared to placebo.
In addition, Flolan may help prevent acute pulmonary hypertensive crises. These episodes can be life-threatening for PAH patients and require emergency medical intervention. By using Flolan regularly, patients may experience fewer crises or less severe episodes when they do occur.
As with any medication, Flolan can cause some side effects in patients. It's important to be aware of these potential side effects prior to starting treatment with Flolan.
One common side effect is pain at the injection site. This can occur due to the continuous infusion pump that delivers Flolan into your bloodstream. The pain may range from mild discomfort to severe pain and may require medical attention if it persists for a prolonged period.
Flolan is a medication that has proven to be a useful treatment for patients suffering from pulmonary arterial hypertension. It works by dilating the blood vessels in the lungs and improving blood flow, which can help reduce symptoms such as shortness of breath and fatigue.
It's important to note that while Flolan has been available for several years, new treatments continue to emerge. Veletri is one such alternative that may offer similar benefits with fewer side effects.
1.
Sub-Q Ketamine is Safe and Very Effective for Severe Depression.
2.
Study indicates that exercise can help colon cancer survivors live as long as matched individuals
3.
Contradictory Results Are Found in Two Pembrolizumab Trials for Head and Neck Cancer.
4.
Can Concurrent Boost Safely Shorten Breast Cancer Radiation?
5.
Positive Trials; Malignancies Increasing in Younger Adults; Andre Braugher's Cancer Dx.
1.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
2.
Antibody-Drug Conjugates in Oncology: Breakthroughs, Clinical Updates, and Pipeline Innovation
3.
Navigating the Stages of Thyroid Cancer: A Guide for Patients
4.
Polycythemia Vera: A Historical Perspective and Contemporary Management
5.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
3.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
4.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation